Evidence map›Paper›PMID 33483620›Full record

ArticleLeukemia2021

Correction: Outcomes in first relapsed-refractory younger patients with mantle cell lymphoma: results from the MANTLE-FIRST study.

Carlo Visco, Alice Di Rocco, Andrea Evangelista, Francesca Maria Quaglia, Maria Chiara Tisi, Lucia Morello, Vittorio Ruggero Zilioli, Chiara Rusconi, Stefan Hohaus, Roberta Sciarra and 23 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Leukemia, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

33 authors.

Carlo ViscoDepartment of Medicine, Section of Hematology, University of Verona, Verona, Italy. carlo.visco@univr.it.ORCID http://orcid.org/0000-0003-2863-0883
Alice Di RoccoDepartment of Translational and Precision Medicine, Sapienza University, Rome, Italy.
Andrea EvangelistaUnit of Clinical Epidemiology, Azienda Ospedaliera Universitaria Città della Salute e della Scienza and CPO Piemonte, Turin, Italy.
Francesca Maria QuagliaDepartment of Medicine, Section of Hematology, University of Verona, Verona, Italy.ORCID http://orcid.org/0000-0003-4347-3775
Maria Chiara TisiCell Therapy and Hematology, San Bortolo Hospital, Vicenza, Italy.
Lucia MorelloHumanitas Clinical and Research Center-IRCCS, Humanitas Cancer Center, via Manzoni 56, 20089, Rozzano, Milan, Italy.
Vittorio Ruggero ZilioliHematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Chiara RusconiHematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Stefan HohausHematology, Fondazione Policlinico Universitario A. Gemelli, Università Cattolica del Sacro Cuore, Rome, Italy.ORCID http://orcid.org/0000-0002-5534-7197
Roberta SciarraHaematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Alessandro ReHematology, Spedali Civili, Brescia, Italy.
Cristina TecchioDepartment of Medicine, Section of Hematology, University of Verona, Verona, Italy.
Annalisa ChiappellaHematology and Bone Marrow Transplantation, IRCSS Istituto Nazionale Tumori, Milan, Italy.
Ana Marin-NieblaHematology, Vall d'Hebron Institut of Oncology, Barcelona, Spain.ORCID http://orcid.org/0000-0002-7592-6815
Rory McCullochHaematology, University of Plymouth and Derriford Hospital, Plymouth, United Kingdom.
Guido GiniHematology, Department of Clinical and Molecular Sciences, Marche Polytechnic University, Ancona, Italy.
Tommasina PerroneHematology, University of Bari, Bari, Italy.
Luca NassiHematology, Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy.
Elsa PenneseHematology, UOSD "Centro Diagnosi e Terapia dei Linfomi", PO Santo Spirito, Pescara, Italy.
Piero Maria StefaniHematology, General Hospital Ca' Foncello, Treviso, Italy.
Maria Christina CoxHematology, AOU Sant'Andrea, Rome, Italy.
Valentina BozzoliHematology, P.O. V. Fazzi, Lecce, Italy.
Alberto FabbriHematology, Azienda Ospedaliera Universitaria Senese & University of Siena, Siena, Italy.
Valentina PolliHematology, Ospedale degli Infermi, Rimini, Italy.
Simone FerreroHematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino/"Città della Salute e della Scienza di Torino" University Hospital, Turin, Italy.
Maria Isabel Alvarez De CelisHematology, AUSLL/IRCCS Santa Maria Nuova Hospital, Reggio Emilia, Italy.
Antonello SicaHematology, Policlinico di Napoli, Napoli, Italy.
Luca PetrucciDepartment of Translational and Precision Medicine, Sapienza University, Rome, Italy.
Luca ArcainiHaematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.ORCID http://orcid.org/0000-0002-9504-991X
Simon RuleHaematology, University of Plymouth and Derriford Hospital, Plymouth, United Kingdom.ORCID http://orcid.org/0000-0001-8937-6351
Mauro KramperaDepartment of Medicine, Section of Hematology, University of Verona, Verona, Italy.ORCID http://orcid.org/0000-0002-7280-2040
Umberto VitoloCandiolo Cancer Institute, FPO-IRCCS, Candiolo (Turin), Italy.
Monica BalzarottiHumanitas Clinical and Research Center-IRCCS, Humanitas Cancer Center, via Manzoni 56, 20089, Rozzano, Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33483620

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.